Appointment New Patient Appointment or 214-645-8300

Appointment New Patient Appointment or 214-645-8300

More Blogs

MedBlog

Todd Aguilera, M.D., Ph.D.

New drug could double survival for eligible patients with pancreatic cancer

New drug could double survival for eligible patients with pancreatic cancer

A new drug called daraxonrasib may double survival for some patients with advanced pancreatic cancer. Learn who may be eligible and how it works.

Todd Aguilera, M.D., Ph.D.

July 30, 2026